Cilostazol inhibits accumulation of triglyceride in aorta and platelet aggregation in cholesterol-fed rabbits.
Cilostazol is clinically used for the treatment of ischemic symptoms in patients with chronic peripheral arterial obstruction and for the secondary prevention of brain infarction. Recently, it has been reported that cilostazol has preventive effects on atherogenesis and decreased serum triglyceride...
Main Authors: | Hideki Ito, Kenji Uehara, Yutaka Matsumoto, Ayako Hashimoto, Chifumi Nagano, Manabu Niimi, Goro Miyakoda, Keisuke Nagano |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3382212?pdf=render |
Similar Items
-
Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin.
by: Yuka Keyamura, et al.
Published: (2014-01-01) -
Cilostazol Induces PGI2 Production via Activation of the Downstream Epac-1/Rap1 Signaling Cascade to Increase Intracellular Calcium by PLCε and to Activate p44/42 MAPK in Human Aortic Endothelial Cells.
by: Ayako Hashimoto, et al.
Published: (2015-01-01) -
Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: Evaluation using black blood magnetic resonance imaging
by: Hideki Ito, et al.
Published: (2008-10-01) -
Uptake and metabolism of circulating chylomicron triglyceride by rabbit aorta
by: Alan Vost
Published: (1972-11-01) -
Effect of atherosclerosis on lysosomal cholesterol esterase activity in rabbit aorta
by: P Brecher, et al.
Published: (1977-03-01)